Federal contractors / EAGLE HEALTH, LLC

Federal contract award

75F40120F19002

NATIONAL CAPITAL REGION FDA OCCUPATIONAL HEALTH CLINIC SERVICES

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Health and Human Services
OfficeFDA OFFICE OF ACQ GRANT SVCS
NAICS621498 — All Other Outpatient Care Centers
PSCQ201 — MEDICAL- MANAGED HEALTHCARE
Parent award / vehicle75F40119D10029
Set-asideNot reported
Pricing typeTIME AND MATERIALS
Obligations$10.9M
Current contract value$10.9M
Potential contract value / ceiling$10.9M
Start dateFeb 28, 2020
Current end dateMar 1, 2023
Potential end dateMar 18, 2026
Latest award activityMar 18, 2026
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 10 of 10 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Mar 18, 2026P00009$0NATIONAL CAPITAL REGION FDA OCCUPATIONAL HEALTH CLINIC SERVICES
Feb 15, 2023P00008$0NATIONAL CAPITAL REGION FDA OCCUPATIONAL HEALTH CLINIC SERVICES
May 17, 2022P00007$0NATIONAL CAPITAL REGION FDA OCCUPATIONAL HEALTH CLINIC SERVICES
Feb 11, 2022P00006$4.2MNATIONAL CAPITAL REGION FDA OCCUPATIONAL HEALTH CLINIC SERVICES
Sep 29, 2021P00005$0NATIONAL CAPITAL REGION FDA OCCUPATIONAL HEALTH CLINIC SERVICES
Jun 25, 2021P00004$0NATIONAL CAPITAL REGION FDA OCCUPATIONAL HEALTH CLINIC SERVICES
Apr 19, 2021P00003$1.7MNATIONAL CAPITAL REGION FDA OCCUPATIONAL HEALTH CLINIC SERVICES
Feb 25, 2021P00002$2.3MNATIONAL CAPITAL REGION FDA OCCUPATIONAL HEALTH CLINIC SERVICES
Sep 18, 2020P00001$334.8KNATIONAL CAPITAL REGION FDA OCCUPATIONAL HEALTH CLINIC SERVICES
Feb 28, 20200$2.3MNATIONAL CAPITAL REGION FDA OCCUPATIONAL HEALTH CLINIC SERVICES

Research next steps

  1. Verify whether remaining options may extend performance beyond the current end date.
  2. Confirm the ordering vehicle and your eligibility or a qualified teaming route.
  3. Review the award scope and buyer evidence before making a bid/no-bid decision.